| Recruiting | 1/2 | 48 | Europe | MB-CART19.1, CD19-targeting CAR T cells, Anti-CD19 CAR T cells | Miltenyi Biomedicine GmbH | Acute Lymphoblastic Leukemia Recurrent, B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, Chronic Lymphocytic Leukemia Recurrent, Chronic Lymphocytic Leukemia Refractory | 12/24 | 12/24 | | |
| Recruiting | N/A | 40 | Europe | MB-CART19.1, CD19-targeting CAR T cells, Anti-CD19 CAR T cells, MB-CART20.1, CD20-targeting CAR T cells, Anti-CD20 CAR T cells, MB-CART2019.1, CD20/CD19-targeting CAR T cells, Anti-CD20/CD19 CAR T cells | Miltenyi Biomedicine GmbH | Melanoma Stage III, B-cell Non Hodgkin Lymphoma, Pediatric ALL, Childhood Non-Hodgkin Lymphoma, Acute Lymphatic Leukemia, Chronic Lymphatic Leukemia, Melanoma Stage IV | 12/40 | 12/40 | | |